Embecta financials
$5.76−2.87%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY23 Sep 30 | FY22 Sep 30 |
|---|---|---|---|---|
| Revenue | $1.08B | $1.12B | $1.12B | $1.13B |
| Gross profit | $676.8M | $735.2M | $749.9M | $774.9M |
| Gross margin | 62.6% | 65.5% | 66.9% | 68.6% |
| Operating income | $242.1M | $166.8M | $221.5M | $309.6M |
| Net income | $95.4M | $78.3M | $70.4M | $223.6M |
| Net margin | 8.8% | 7.0% | 6.3% | 19.8% |
| Diluted EPS | $1.62 | $1.34 | $1.22 | $3.89 |
| EBITDA | $282.8M | $203.0M | $256.6M | $400.2M |
| Operating cash flow | $191.7M | $35.7M | $67.7M | $412.2M |
| Free cash flow | $182.4M | $19.9M | $41.2M | $388.6M |
| Diluted shares | 58.9M | 58.3M | 57.8M | 57.5M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|
| Cash & equivalents | $225.5M | $267.5M | $326.3M | $330.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.43B | $1.61B | $1.64B | $1.64B |
| Total assets | $1.09B | $1.29B | $1.21B | $1.09B |
| Total liabilities | $1.74B | $2.02B | $2.04B | $1.98B |
| Shareholders' equity | -$650.6M | -$738.3M | -$821.7M | -$891.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology